Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.

Also called NCT03299296

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03299296
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03299296. Randomized; single masking; primary purpose prevention. Start 2017-01-01 (actual); primary completion 2018-01-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
Condition
Thromboses, Deep Vein
Condition
Surgery--Complications
Intervention (Drug)
Rivaroxaban 10 Milligrams
Intervention (Drug)
Enoxaparin 40 Milligrams/0.4 Milliliters Prefilled Syringe
Lead sponsor
Ahmed AbdelMoneim Hassan Ali (class: other)
Collaborator
Beni-Suef University (class: other)

Record details

Record id
cardio:ct-nct03299296
Content hash
66ffb4d929063536f99967c0b9fef6b1a5ec46fb4903693dc34faceda3a588cd